A significant discovery in cancer investigation is emerging with the use of mini-antibodies to re-engage dysfunctional p53. This essential cancer protector protein is frequently lost in many types of malignancies, https://keybookmarks.com/story21967606/nanobodies-reactivate-the-p53-protein-new-new-approach-for-malignant-management